Company

Press

Jun 07, 2013

NIH expects AiCure Technologies's new adherence monitoring platform to have "a significant impact… [and] widespread application in research and in care."

May 15, 2013

Confirming Medication Adherence in Clinical Trials through Computer Vision

Dec 19, 2012

Ai Cure Technologies opens the Innovation Showcase at CNS Summit

Dec 12, 2012

Ai Cure Technologies adherence solutions registered with FDA under 510K Class 1 Exempt status